March 3 (Reuters) - U3O8 Corp UWEh.V :
* U3O8 CORP. ANNOUNCES PROPOSED REVERSE TAKEOVER TRANSACTION WITH DIAGNOSTIC LAB CORPORATION, INC.
* U3O8 CORP - PROPOSED TRANSACTION IS ANTICIPATED TO BE COMPLETED BY WAY OF SHARE EXCHANGE
* U3O8 CORP - DIAGNOSTIC LAB CORPORATION, INC. IS SEEKING A LISTING IN CANADA THROUGH A RTO TRANSACTION WITH U3O8 CORP
* U3O8 CORP - DLC WILL ADVANCE U3O8 AN INTEREST-FREE BRIDGE LOAN THAT WILL BE USED PRIMARILY TO PAY EXPENSES RELATING TO PROPOSED TRANSACTION
* U3O8 CORP - IN ADDITION, DLC SHALL UNDERTAKE A SERIES OF FINANCINGS TO FUND BUSINESS ON TERMS TO BE ANNOUNCED
* U3O8 CORP - DLC WILL BECOME A WHOLLY OWNED SUBSIDIARY OF U3O8 CORP
* U3O8 - UPON COMPLETION, ANTICIPATED THAT ALL DIRECTORS, OFFICERS OF CO OTHER THAN 1 NOMINEE DIRECTOR WILL RESIGN & BE REPLACED BY NOMINEES OF DLC
* U3O8 CORP - ANTICIPATED THAT PROPOSED TRANSACTION WILL NOT BE A "NON-ARM'S LENGTH TRANSACTION"
* U3O8 - A NUMBER OF RESULTING ISSUER SHARES REPRESENTING 85% OF TOTAL RESULTING ISSUER SHARES WILL BE ISSUED TO DLC SHAREHOLDERS